Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma

Rhinology

Volumn 48, Issue 3, 2010, Pages 325-330

  Olsson, P ^a   Ehnhage, A ^a,b   Nordin, S ^d   Stjarne P ^a,c  

^a Division of Otorhinolaryngology ^*  (Sweden)

^b Nacka Närsjukhus Proxima AB   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Endoscopic sinus surgery; Fluticasone propionate nasal drops; Nasal polyposis; Quality of life; Randomized controlled trial

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; FLUTICASONE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; HUMAN; MALE; MIDDLE AGED; NOSE POLYP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; COMORBIDITY; DOUBLE-BLIND METHOD; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; QUALITY OF LIFE;

EID: 79952055303     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino09.142     Document Type: Article

References (31)

1. Fokkens W, Lund V, Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007; 45: 97-101.
2. Samter M, Beers RF, Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Int Med. 1968; 68: 975-983.
3. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc. 1996; 17: 243-249. (Pubitemid 26403404)
4. Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999; 28: 717-722. (Pubitemid 29401332)
5. Johansson L, Åkerlund A, Holmberg K, et al. Prevalence of nasal polyps in adults: The Skovde population-based study. Ann Otol Rhinol Laryngology. 2003; 112: 625-629. (Pubitemid 36858945)
6. Janson C, Chinn S, Jarvis D, et al. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997; 10: 1795-1802. (Pubitemid 27368372)
7. Larsson ML, Frisk M, Hällström J, et al. Environmental tobacco smoke exposure during childhood is associated with increased prevalence of asthma in adults. Chest. 2001; 120: 711-717. (Pubitemid 32885439)
8. Radenne F, Lamblin C, Vandezande LM, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol. 1999; 104: 79-84. (Pubitemid 29364483)
9. Alobid I, Benitez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: Comparison between the effects of medical and surgical treatments. Allergy. 2005; 60: 452-458. (Pubitemid 40332969)
10. Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps: The role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy. 2008; 63: 1267-1279.
11. Alobid I, Benitez P, Bernal-Sprekelsen M, et al. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res. 2005; 14: 789-793. (Pubitemid 40576864)
12. Mygind N. Advances in the medical treatment of nasal polyps. Allergy. 1999; 54 Suppl 53: 12-16. (Pubitemid 29331678)
13. Tuncer U, Soylu L, Aydogan B, et al. The effectiveness of steroid treatment in nasal polyposis. Auris, Nasus, Larynx. 2003; 30: 263-268. (Pubitemid 36960231)
14. Penttilä M, Poulsen P, Hollingworth K, et al. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: A placebo-controlled randomized study in adult patients. Clin Exp Allergy. 2000; 30: 94-102. (Pubitemid 30093886)
15. Holmström M. Clinical performance of fluticasone propionate nasal drops. Allergy. 1999; 54 Suppl 53: 21-25. (Pubitemid 29331680)
16. Ehnhage A, Olsson P, Kölbäck KG, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy. 2009; 64: 762-769.
17. Morley AD, Sharp HR. A review of sinonasal outcome scoring systems - which is best? Clin Otolaryngol. 2006; 31: 103-109.
18. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey(SF-36). I. Conceptual framework and item selection. Medical care. 199236). I. Conceptual framework and item selection. Medical care. 1992; 3: 473-483.
19. Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992; 34: 220-233.
20. Alobid I, Benitez P, Valero A, et al. The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis. Otolaryngol Head Neck Surg. 2006; 134: 609-612.
21. Johansson L, Brämerson A, Holmberg K, et al. Clinical relevance of nasal polyps in individuals recruited from a general populationbased study. Acta Oto-Laryngologica. 2004; 124: 77-81. (Pubitemid 38177855)
22. Ware JE, Konsinski M Keller SD. SF-36 physical and mental health summary scales: A users manual. Boston, Massachusetts. The Health Institute New England Medical Center, 1994.
23. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: Results from normative population. J Clin Epidemiol. 1998; 51: 1105-1113. (Pubitemid 28527166)
24. Sullivan M, Karlsson J, Ware JE, Jr. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995; 41: 1349-1358.
25. Sullivan M, Karlsson J, Taft C. SF-36 Hälsoenkät: Svensk Manual och Tolkningsguide, 2:a upplagan. Göteborg: Sahlgrenska Universitetssjukhuset, 2002.
26. McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993 Mar; 31: 247-263.
27. Chester AC, Antisdel JL, Sindwani R. Symptom-specific outcomes of endoscopic sinus surgery: A systematic review. Otolaryngol Head Neck Surg. 2009; 140: 633-639.
28. Hopkins C, Slack R, Lund V, et al. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009; 119: 2459-2465.
29. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994; 94: 182-188.
30. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Resp Crit Care Med. 1994; 149: 371-375.
31. Hummel T, Nordin S. Olfactory disorders and their consequences for quality of life. Acta Oto-Laryngologica. 2005; 125: 116-121. (Pubitemid 40293199)